Electromed, Inc.

ASE: ELMD
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Electromed, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get ELMD Z-Score →

About Electromed, Inc.

Healthcare Medical Devices
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

📊 Fundamental Analysis

Electromed, Inc. demonstrates a healthy profit margin of 13.1%.

The company recently reported 16.3% revenue growth, which is well above average for the Healthcare sector.

Return on Equity (ROE) is 20.2%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.

At a current price of $24.12, ELMD currently sits at the 49th percentile of its 52-week range (Range: $17.73 - $30.73).

💰 Valuation Insight

ELMD is valued broadly in line with the sector at a PE of 23.42. Analysts anticipate some earnings pressure, with a higher forward PE.

🏥 Financial Health

⚠️ Profit Margin Moderate
Debt/Equity Excellent
Revenue Growth Excellent
⚠️ Return on Equity Moderate
Beta (Risk) Low Volatility

Key Financials

Market Cap
$201.17M
Trailing P/E
23.42
Forward P/E
39.54
Beta (5Y)
0.32
52W High
$30.73
52W Low
$17.73
Avg Volume
66K
Day High
Day Low
Get ELMD Z-Score on Dashboard 🚀